InfiCure Bio, a life-science company in the field of inflammation and fibrosis, has characterized a new preclinical model that spontaneously develops chronic inflammation and fibrosis in multiple organs. The model is called the non-obese diabetic inflammation and fibrosis (N-IF) mouse and you can read all about it here.
